← Back

QuadMedicine, Inc.

QuadMedicine, Inc. is engaged in the research, development, and production of healthcare vaccination needles based on microneedle array patch (MAP) technology. The company develops vaccines for children in remote areas to protect them from infectious diseases such as diphtheria, tetanus, polio, measles, and hepatitis B. It focuses on technology integration for medical and pharmaceutical microneedle development, and offers services ranging from fundamental MAP research and prototyping to MAP production for clinical trials. QuadMedicine was incorporated in 2016 and is headquartered in Seongnam-si, South Korea.

Country
Price · split & dividend adjusted
News & notes moving 464490.KQ